Autopsy report · NCT04576000

Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis

“Not able to meet recruitment targets”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 3 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Alimentiv Inc.

Sponsor type

University, hospital or other

Conditions

Ulcerative Colitis

Interventions

Janus Kinase Inhibitor

Participants

3

Sites

1

Countries

Netherlands

Trials that died the same way

• Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer
  “Difficulties in meeting recruitment target” (91% match in meaning)
• Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study
  “Difficulty with meeting recruitment targets” (91% match in meaning)
• Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
  “Target recruitment not reached” (89% match in meaning)
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
  “Unable to achieve recruitment target.” (84% match in meaning)
• High-Dose Vitamin D Induction in Optic Neuritis
  “inability to meet recruitment goals” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.